
There is a very good question to ask at the beginning of every project: “What does success look like?” If …

The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …

The great physicist Lord Kelvin said: “If you can measure something, and express it in numbers, then you know something …
Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …

Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …

It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …

What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …

In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

There was once a company that had an amusing form of words for admonishing people. It went something like this: …
I’ve often said that however bad one’s research, it’s possible to get it published somewhere. I have been thinking about …
What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …

I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …